SCHEMBL10132623

SCHEMBL10132623

COc1cc2c(NC(=O)c3c(Br)ccc4c3OCO4)cccc2c(Cc2ccccc2)c1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
HPGD P15428 5/20 0.42
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
MAPT P10636 3/20 0.42
LMNA P02545 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 3/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PKM P14618 1/20 0.38
MAPK1 P28482 2/20 0.38
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
EDNRB P24530 1/20 0.37
EDNRA P25101 1/20 0.37
TARBP2 Q15633 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10132615 0.86 RXFP1 (0.46) ALDH1A1HPGDNPC1RAB9AMAPT
SCHEMBL10132597 0.85 RXFP1 (0.45) ALDH1A1HPGDNPC1RAB9AMAPT
SCHEMBL10132624 0.83 EDNRA (0.39) ALDH1A1HPGDMAPTLMNASMN1; SMN2
SCHEMBL10132634 0.82 RXFP1 (0.45) ALDH1A1HPGDNPC1RAB9AMAPT
SCHEMBL10132867 0.80 MAPT (0.47) ALDH1A1HPGDNPC1RAB9AMAPT
SCHEMBL420470 0.78 MAPT (0.44) ALDH1A1HPGDNPC1RAB9AMAPT
Benzamide SCHEMBL423609 0.73 MAPT (0.42) ALDH1A1HPGDNPC1RAB9AMAPT
SCHEMBL10163103 0.70 LMNA (0.43) HPGDMAPTLMNASMN1; SMN2KDM4E
SCHEMBL10132602 0.69 NPSR1 (0.43) ALDH1A1HPGDRAB9AMAPTLMNA
SCHEMBL10132694 0.69 PKM (0.42) HPGDLMNASMN1; SMN2KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 US disclosed
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 US disclosed
WO-2010083436-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS CCNT1, XPO4, XDH ALDH1A1 3095/4885HPGD 1643/4885NPC1 2668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.